dc.contributor.author | Elias-Jones, A. C. | |
dc.contributor.author | Dhillon, S. | |
dc.contributor.author | Greenough, A. | |
dc.date.accessioned | 2014-02-26T16:00:29Z | |
dc.date.available | 2014-02-26T16:00:29Z | |
dc.date.issued | 1985-10 | |
dc.identifier.citation | Elias-Jones , A C , Dhillon , S & Greenough , A 1985 , ' The efficacy of oral theophylline in ventilated premature infants ' , Early Human Development , vol. 12 , no. 1 , pp. 9-14 . | |
dc.identifier.issn | 1872-6232 | |
dc.identifier.uri | http://hdl.handle.net/2299/12924 | |
dc.description.abstract | 40 ventilated premature infants, with gestational ages of 24-34 weeks and a mean birthweight of 1422 g, were entered into a randomised controlled trial. 20 of the infants received orally 5 mg/ml anhydrous theophylline dissolved in 20% pure alcohol, with a loading dose of 5 mg/kg and then 1.25 mg/kg every 6 h. Plasma samples were assayed via an emit enzyme immunoassay, demonstrating satisfactory serum levels in all infants at 54 h after the loading dose. Possible side-effects were seen only in two infants, in one a tachycardia (220 beats/min) and the other became agitated during treatment | en |
dc.language.iso | eng | |
dc.relation.ispartof | Early Human Development | |
dc.title | The efficacy of oral theophylline in ventilated premature infants | en |
dc.contributor.institution | Health & Human Sciences Research Institute | |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Department of Pharmacy | |
dc.contributor.institution | Centre for Clinical Practice, Safe Medicines and Drug Misuse Research | |
dc.contributor.institution | Patient and Medicines Safety | |
dc.description.status | Peer reviewed | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |